Hot Products

beta-Costic acid
Catalog No: CFN98498

The use of costic acid and other components from the plant Dittrichia viscosa (Greek: aconiza) and related species for the preparation of acaricidal products used against the acari Varroa destructor as parasite of the honey bee.

beta-Cryptoxanthin
Catalog No: CFN70370

beta-Cryptoxanthin has a stimulatory effect on cell proliferation and biochemical components in osteoclastic MC3T3-E1 cells, and that the carotenoid can stimulate transcriptional activity in the cells.

Beta-D-glucopyranosiduronic acid
Catalog No: CFN92281

Reference standards.

Beta-D-glucopyranosyl oleanolate
Catalog No: CFN90865

Beta-D-glucopyranosyl oleanolate is a natural product from Hedera nepalensis.

Beta-Dimorphecolic acid (9(S)-HODE)
Catalog No: CFN95313

Anti-inflammatory activity.

Beta-Elemonic acid
Catalog No: CFN90991

Beta-Elemonic acid exhibits anti-inflammatory, and anti-cancer effects, it inhibits proliferation by inducing hypoploid cells and cell apoptosis, the anticancer effects of beta-Elemonic acid are related to the MAPK signaling pathway, ROS activation and glutathione depletion in human A549 lung cancer cells. Beta-Elemonic acid exhibits prolyl endopeptidase inhibitory activities.

beta-Estradiol
Catalog No: CFN90035

Estradiol, or more precisely, 17β-estradiol, is a human sex hormone and steroid, and the primary female sex hormone. Beta-estradiol has been considered to be a neurotrophic agent, beta-estradiol at a dose of 0.25 microg/day prevents ischemia-induced learning disability and neuronal loss at early stages after transient forebrain ischemia, possibly via a receptor-mediated pathway without attenuating free radical neurotoxicity.

beta-Eudesmol
Catalog No: CFN99537

Beta-eudesmol has potential anti-angiogenic and anti-tumour activities, it inhibits angiogenesis by suppressing CREB activation in growth factor signalling pathway, is an inhibitor of tumour growth. Beta-eudesmol induces neurite outgrowth in rat pheochromocytoma cells accompanied by an activation of mitogen-activated protein kinase, it may be a promising lead compound for potentiating neuronal function, and the drug may be useful in helping to clarify the mechanisms underlying neuronal differentiation.

beta-Glucogallin
Catalog No: CFN70245

Beta-glucogallin , a recently described Aldose reductase (AR) inhibitor, has antioxidant and anti-inflammatory activities.

Beta-Hederin
Catalog No: CFN98558

Beta-Hederin has antileishmanial activity; it has apoptotic effect on breast cancer cells, it could be a promising candidate for chemotherapy of breast cancer.